Martin D. Zielinski, M.D.

Martin D. Zielinski, M.D., of Mayo Clinic in Rochester, Minn., achieves immense satisfaction in studying clinical problems and coming up with better solutions to benefit the patients in his care.

Dr. Zielinski pursued the KL2 Mentored Career Development Program so he could have dedicated time to focus on research and didactic endeavors independent of clinical responsibilities. His research involves determining and validating the "threshold" for aggressive blood transfusion in patients who are bleeding to death.

Massive transfusion is arbitrarily defined as the replacement of a patient's total blood volume in less than 24 hours, or as the acute administration of more than half the patient's estimated blood volume per hour. The complications of massive transfusion are exacerbated by inadequate or excessive transfusion.

Dr. Zielinski's long-term goal is the implementation of a warm, fresh, whole-blood transfusion program for hemorrhagic shock. This novel approach to blood transfusion replaces exactly what the hemorrhaging patients are losing — namely, warm blood without the chemicals necessary for long-term storage. An organic approach such as this can potentially save more lives than the current paradigm.

A native Minnesotan with family in Rochester, Minn., and the Twin Cities, Dr. Zielinski says Mayo took on a mythical status for him as the place to go for advanced medical care. "When my wife and I sought our training we chose to study at the best institution in the world. We were fortunate enough to be hired on a permanent basis," he says.

"I'm excited to be a part of a strong, diverse research community where I can expand my horizons outside the world of surgery," says Dr. Zielinski.


  • May 3, 2013
  • PRO099449